Washington University School Of Medicine
Clinical trials sponsored by Washington University School Of Medicine, explained in plain language.
-
New hope for colorectal cancer: experimental drug combo enters phase 2 trial
Disease control Not yet recruitingThis phase 2 trial tests whether adding an experimental drug called tovecimig to standard chemotherapy (FOLFIRI) can shrink tumors or slow cancer growth in people with metastatic colorectal cancer who have already tried one prior treatment. The study will enroll 25 participants a…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New personalized vaccine trial aims to boost immune attack on aggressive breast cancer
Disease control Not yet recruitingThis early-phase trial is testing whether a personalized cancer vaccine, made from a patient's own tumor, can safely boost the immune system's ability to fight triple negative breast cancer. About 30 newly diagnosed patients will receive the vaccine along with standard chemothera…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for tough leukemia? drug duo targets TP53 mutations
Disease control Not yet recruitingThis early-phase study tests a new drug (ATRN-119) combined with a standard chemotherapy (decitabine) in 27 adults with acute myeloid leukemia or high-risk myelodysplastic syndrome that has a TP53 gene change. The main goals are to find a safe dose and see if the combo can shrink…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Laser zaps brain tumor, then immunotherapy fights back: new hope for glioblastoma?
Disease control Not yet recruitingThis study tests a new approach for recurrent glioblastoma, an aggressive brain cancer. It combines a minimally invasive laser that heats and destroys tumor tissue (LiTT) with an immunotherapy drug called cemiplimab, which helps the immune system attack cancer cells. About 99 par…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a statin make breast cancer therapy more effective?
Disease control Not yet recruitingThis study tests whether adding lovastatin, a common cholesterol-lowering drug, can help the cancer treatment trastuzumab deruxtecan work better in people with HER2-low or ultralow advanced breast cancer. About 60 participants will receive both drugs to see if more tumors shrink …
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Triple therapy aims to shrink head and neck tumors before surgery
Disease control Not yet recruitingThis study tests a combination of an experimental drug (ficerafusp alfa), an immunotherapy (pembrolizumab), and targeted radiation before surgery for people with advanced head and neck cancer that is HPV-negative. About 45 participants will receive these treatments over several w…
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New triple therapy aims to slow advanced lung cancer
Disease control Not yet recruitingThis study tests a new combination of three drugs (nivolumab, ipilimumab, and nogapendekin alfa inbakicept) for people with stage IV or recurrent non-small cell lung cancer. The goal is to see if this treatment helps keep the cancer from growing longer than standard two-drug ther…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
One pill to rule them all: new study aims to simplify heart failure treatment
Disease control Not yet recruitingThis study tests whether a single pill containing four standard heart failure medications can help patients take their medicines more regularly and reduce hospitalizations and death. About 1,656 adults with heart failure and reduced pumping function will be randomly assigned to r…
Phase: PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New program aims to transform diabetes treatment in nigeria
Disease control Not yet recruitingThis study will test a program based on WHO guidelines to improve diabetes screening and care in 10 primary health centers in Nigeria. About 2,800 adults with or at risk for diabetes will take part. The goal is to see if the program helps more people get diagnosed and treated.
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New study aims to help childhood leukemia survivors fight weight gain
Disease control Not yet recruitingThis study compares two weight management programs for children who have had acute lymphoblastic leukemia (ALL). About 80 children and their caregivers will be randomly assigned to either a basic educational program or a more intensive guided self-help program. The goal is to see…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug combo aims to keep lung cancer in check after initial treatment
Disease control Not yet recruitingThis early-phase study tests whether adding an experimental drug (DSP-0390) to the immunotherapy atezolizumab can safely help prevent extensive stage small cell lung cancer from growing back after initial chemotherapy and immunotherapy. About 20 adults whose cancer did not worsen…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Earpiece zaps nerves to tame aortic tear inflammation
Disease control Not yet recruitingThis study tests whether a special earpiece that stimulates the vagus nerve can help people with a type B aortic dissection. The device is used for 20 minutes twice a day for two weeks. Researchers will check if it lowers inflammation and helps control blood pressure. Sixty adult…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Stomach cancer trial combines chemo and quick radiation to boost remission
Disease control Not yet recruitingThis phase 2 trial tests giving short course radiation therapy along with standard chemotherapy before surgery for stomach cancer. The goal is to see if this total neoadjuvant therapy leads to a higher rate of complete cancer disappearance, with fewer side effects than traditiona…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could a High-Fat diet prevent aortic surgery in marfan patients?
Disease control Not yet recruitingThis pilot study tests whether a carefully supervised ketogenic diet can help people with Marfan syndrome who have a chronic aortic dissection avoid surgery for one year. Fifteen adults aged 18-50 will follow the diet with guidance from a dietitian, measure their blood ketones at…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug combo aims to slow advanced cervical cancer
Disease control Not yet recruitingThis study tests whether adding a glutaminase inhibitor (telaglenastat) to standard chemoradiation helps people with advanced cervical cancer live longer without the disease getting worse. About 42 adults with stage III–IVA cervical cancer will receive the drug alongside standard…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Massive new program aims to tame Nigeria's hypertension crisis
Disease control Not yet recruitingThis study expands a successful blood pressure program to 50 primary health centers across five Nigerian states. Over 10,000 adults with high blood pressure will receive simplified care from trained non-physician health workers, following the WHO HEARTS package. The goal is to im…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New scan could sharpen detection of head and neck cancers
Diagnosis Not yet recruitingThis study tests a new radioactive tracer called 64Cu-DOTA-ECL1i that aims to make PET scans more accurate for head and neck cancer. Researchers will enroll 90 adults with newly diagnosed or recurrent/metastatic head and neck squamous cell carcinoma. The goal is to see if this tr…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
Can a risk score and MRI outsmart dense breasts?
Diagnosis Not yet recruitingThis study looks at whether adding an MRI to the yearly mammogram can help find breast cancer earlier in women with dense breasts. Participants will have a mammogram and a risk score calculated from it. Those with a high risk score will be offered an MRI. The goal is to see if th…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
New program aims to end isolation after brain injury
Symptom relief Not yet recruitingThis study tests a 12-week program where a person with traumatic brain injury and a close supporter work with a therapist to improve communication and emotional support. The goal is to reduce isolation and improve health. The study involves 60 participants and focuses on whether …
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Magic mushroom compound tested for depression in new brain scan study
Symptom relief Not yet recruitingThis study will test whether psilocybin, the active ingredient in magic mushrooms, can help treat depression. Fifty adults with depression will receive a 25 mg capsule of synthetic psilocybin along with therapy. Researchers will use MRI brain scans and other tests to see how psil…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New group program aims to help brain injury survivors rejoin social life
Symptom relief Not yet recruitingThis study tests a 12-session group program called ENGAGE-TBI for adults who had a traumatic brain injury (TBI) at least 6 months ago. The program, led by an occupational therapist and a TBI survivor, focuses on social skills and problem-solving. Researchers want to see if it's p…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New nebulizer may ease chronic sinusitis symptoms
Symptom relief Not yet recruitingThis study tests if a nebulized steroid (budesonide) delivered via the NasoNeb device is safe and effective for chronic rhinosinusitis. 50 adults with the condition will be randomly assigned to receive either nebulized budesonide or a standard steroid lavage. The main goal is to …
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Can a chatbot treat eating disorders? new study aims to find out
Symptom relief Not yet recruitingThis study will test a smartphone chatbot called Wysa that delivers cognitive-behavioral therapy-based self-help for adults with eating disorders. 800 participants will use the chatbot daily for eight weeks. The goal is to see if this digital tool can reduce eating disorder sympt…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Could a leukemia drug stop deadly brain tumor spread?
Knowledge-focused Not yet recruitingThis early study tests whether asciminib, a drug already approved for leukemia, can get into brain tumors in children and young adults (ages 6-25) with recurrent brain tumors. Some participants will also get sildenafil to see if it helps the drug enter the tumor. The main goal is…
Phase: EARLY_PHASE1 • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jul 01, 2026 23:00 UTC
-
Can a 2-week drug boost scan accuracy for hidden prostate cancer?
Knowledge-focused Not yet recruitingThis study looks at whether taking bicalutamide for two weeks can make PSMA PET/CT scans better at finding small amounts of prostate cancer that standard scans might miss. It involves 20 men with recurrent prostate cancer and very low PSA levels. Participants are randomly assigne…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jul 01, 2026 23:00 UTC
-
New study aims to close racial gap in breast cancer screening
Knowledge-focused Not yet recruitingThis study tests whether a culturally tailored program can help Black women keep their mammogram appointments. About 176 women aged 40 and older who are scheduled for a screening mammogram will take part. The goal is to find better ways to reduce racial disparities in breast canc…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New scan could reveal where cancer drugs go in the body
Knowledge-focused Not yet recruitingThis study tests a new imaging technique called low-count quantitative SPECT (LC-QSPECT) to see how the drug Radium-223 spreads in men with advanced prostate cancer. About 38 men who are already eligible for Radium-223 will get extra scans after their treatment. The goal is to se…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New drug may unmask hidden leukemia cells after treatment
Knowledge-focused Not yet recruitingThis early study tests whether a single injection of motixafortide can help reveal tiny amounts of leukemia cells that remain after initial chemotherapy in people with acute myeloid leukemia (AML). Ten adults who have completed 1-2 cycles of treatment will receive the drug and th…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Aging muscles under the microscope: can exercise clean out hidden fat?
Knowledge-focused Not yet recruitingThis study looks at fat that builds up inside muscles as people age, which may cause inflammation and damage. Researchers will have 16 older adults (ages 65-80) do a 12-week calf exercise program. Before and after, they will measure muscle strength, take CT scans, and analyze sma…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Blood test could spot hidden heart damage in preeclampsia
Knowledge-focused Not yet recruitingThis study looks for proteins in the blood that might show early heart changes in women with preeclampsia, a serious pregnancy condition. Researchers will also use heart ultrasounds to see how the heart changes during pregnancy. The goal is to find ways to predict future heart pr…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Can better teamwork stop cancer before it starts?
Knowledge-focused Not yet recruitingThis study looks at how partnerships between universities and local health departments can help put proven cancer prevention programs into action. Researchers will survey 364 health workers and academics across the U.S. to find out what works best. The goal is to learn how to mak…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Can better staff talk save kids with cancer? new study tests team training
Knowledge-focused Not yet recruitingThis study tests a program to improve how hospital staff communicate when caring for children with cancer in low-resource settings. The program includes training and new protocols for teamwork. Researchers will measure changes in communication quality over six months. Only 8 hosp…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC